sb 202190 has been researched along with Bowel Diseases, Inflammatory in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oshima, T | 1 |
| Pavlick, KP | 1 |
| Laroux, FS | 1 |
| Verma, SK | 1 |
| Jordan, P | 1 |
| Grisham, MB | 1 |
| Williams, L | 1 |
| Alexander, JS | 1 |
1 other study available for sb 202190 and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Regulation and distribution of MAdCAM-1 in endothelial cells in vitro.
Topics: Alkaloids; Animals; Benzophenanthridines; Benzopyrans; Carbazoles; Cell Adhesion Molecules; Cell Lin | 2001 |